120
Participants
Start Date
August 31, 2013
Primary Completion Date
April 30, 2017
Study Completion Date
April 30, 2017
Second Line ITP agents
The treating physicians will select the second line agent and clinical data will be collected.
Columbia University Medical Center, New York
New York-Presbyterian University Hospital of Columbia and Cornell, New York
Children's Hospital of Philadelphia, Philadelphia
Duke University Medical Center, Durham
Children's Healthcare of Atlanta, Atlanta
St. Jude's Hospital, Memphis
Nationwide Children's Hospital, Columbus
Cincinnati Children's Hospital, Cincinnati
James Whitcomb Riley Hospital for Children, Indianapolis
St. John Hospital & Medical Center, Detroit
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Arkansas Children's Hospital, Little Rock
University of Texas Southwestern Medical Center at Dallas, Dallas
Texas Children's Hospital, Houston
Colorado Children's Hospital, Denver
Mattel Children's Hospital, Los Angeles
Children's Hospital of Orange County, Orange
UCSF School of Medicine, San Francisco
Lucile Packard Children's Hospital, Palo Alto
Children's Hospital of Oakland, Oakland
UC Davis Medical Center, Sacramento
Oregon Health and Sciences University, Portland
Seattle Children's, Seattle
Boston Children's Hospital, Boston
Goryeb Children's Hospital, Morristown
Hasbro Children's Hospital, Providence
McMaster Children's Hospital, Hamilton
Children's Hospital of Eastern Ontario, Ottawa
U. de Montreal CHU St. Justine, Montreal
Terrana ITP Research Fund
OTHER
Boston Children's Hospital
OTHER